Literature DB >> 6870249

Biliary metabolites of all-trans-retinoic acid in the rat.

K L Skare, H F DeLuca.   

Abstract

Biliary metabolites from physiological doses of all-trans-[10-3H]retinoic acid were examined in normal and vitamin A-deficient rats. The bile from normal and vitamin A-deficient rats contained approximately 60% of the administered dose following a 24-h collection period. However, vitamin A-deficient rats show a 6-h delay in the excretion of radioactivity compared to normal rats. Retinoyl-beta-glucuronide excretion was particularly sensitive to the vitamin A status of the rats. In normal rats, retinoyl-beta-glucuronide reached a maximum concentration of 235 pmol/ml of bile 2 h following the dose and then rapidly declined. Vitamin A-deficient rats show a relatively constant concentration of this metabolite (100-150 pmol/ml of bile) over a 10-h collection period. Retinoic acid excretion was low in both normal and deficient rats. The concentration of retinotaurine, a recently identified biliary metabolite, was approximately equal to retinoyl-beta-glucuronide in normal rats and appeared in the bile 2 h later than the glucuronide.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870249     DOI: 10.1016/0003-9861(83)90185-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  3 in total

1.  All-trans-retinoic acid distribution and metabolism in vitamin A-marginal rats.

Authors:  Christopher J Cifelli; A Catharine Ross
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08       Impact factor: 4.052

2.  Chronic vitamin A status and acute repletion with retinyl palmitate are determinants of the distribution and catabolism of all-trans-retinoic acid in rats.

Authors:  Christopher J Cifelli; A Catharine Ross
Journal:  J Nutr       Date:  2007-01       Impact factor: 4.798

Review 3.  Clinical pharmacokinetics of tretinoin.

Authors:  M B Regazzi; I Iacona; C Gervasutti; M Lazzarino; S Toma
Journal:  Clin Pharmacokinet       Date:  1997-05       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.